Stock Events

Arrowhead Pharmaceuticals (A2RR34.SA) Q1 2024 Earnings

6FebConfirmed
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-9.42
-5.52
-1.63
2.27

Details

Expected EPS
-3.96984
Actual EPS
-6.153252
Surprise EPS
-2.18
Surprise Percent
+55%

Description

Arrowhead Pharmaceuticals (A2RR34.SA) has reported earnings of -6.153252 per share for Q1 2024.

0 Comments

Share your thoughts